No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
FLGT240517C22500
- 0.30
- 0.000.00%
15min DelayTrading May 15 12:14 ET
0.35High0.25Low
0.35Open0.30Pre Close9 Volume351 Open Interest22.50Strike Price267.00Turnover30.41%IV1.24%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.30Time Value100Contract SizeAmericanOptions Type0.4727Delta0.7168Gamma99.77Leverage Ratio-0.0532Theta0.0007Rho47.16Eff Leverage0.0073Vega
Intraday
- 5D
- 1D
News
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
Collaboration aims to accelerate the development of personalized therapies and transform patient care through the use of precision medicine TAMPA, Fla. & LOS ANGELES--(BUSINESS WIRE)--May 14, 2024-- M
Earnings Release: Here's Why Analysts Cut Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target To US$26.67
Investors in Fulgent Genetics, Inc. (NASDAQ:FLGT) had a good week, as its shares rose 4.4% to close at US$21.49 following the release of its first-quarter results. It looks like the results wer
Analysts Have Conflicting Sentiments on These Healthcare Companies: Fulgent Genetics (FLGT), Cigna (CI) and PROCEPT BioRobotics (PRCT)
Fulgent Genetics Inc (FLGT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
Fulgent Genetics Releases Updated Investor Presentation
Comments
Gainers:
• $Checkmate Pharmaceuticals(CMPI.US$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer(SMCI.US$ +14.3% (earnings report)
• $Plug Power(PLUG.US$ +9.24% (t...
• $Checkmate Pharmaceuticals(CMPI.US$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer(SMCI.US$ +14.3% (earnings report)
• $Plug Power(PLUG.US$ +9.24% (t...
16
1
Insider selling:
$VIZIO(VZIO.US$
$Fulgent Genetics(FLGT.US$
$Cara Therapeutics(CARA.US$
$KnowBe4, Inc.(KNBE.US$
$Coursera(COUR.US$
$Intellia Therapeutics(NTLA.US$
$Natera(NTRA.US$
$DraftKings(DKNG.US$
$Natural Alternatives International(NAII.US$
$Revolve Group(RVLV.US$
$A10 Networks(ATEN.US$
$Zuora(ZUO.US$
Insider Buying
$Spero Therapeutics(SPRO.US$
$Lumos Pharma(LUMO.US$
$Oscar Health(OSCR.US$
$Phibro Animal Health(PAHC.US$
$VIZIO(VZIO.US$
$Fulgent Genetics(FLGT.US$
$Cara Therapeutics(CARA.US$
$KnowBe4, Inc.(KNBE.US$
$Coursera(COUR.US$
$Intellia Therapeutics(NTLA.US$
$Natera(NTRA.US$
$DraftKings(DKNG.US$
$Natural Alternatives International(NAII.US$
$Revolve Group(RVLV.US$
$A10 Networks(ATEN.US$
$Zuora(ZUO.US$
Insider Buying
$Spero Therapeutics(SPRO.US$
$Lumos Pharma(LUMO.US$
$Oscar Health(OSCR.US$
$Phibro Animal Health(PAHC.US$
24
5
, thank you so much for information
$Fulgent Genetics(FLGT.US$ any idea why drop so much?
Read more
Silverbat : Buy at dips and hold for 192